Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Study to Assess the Robustness of the CRC749 Device by Pharmaceutical Performance Following Twice Daily Dosing of MGR001 Administered Via Oral Inhalation in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD)

NCT02474017 is registered in ClinicalTrials.gov with Mylan Pharma UK Ltd. as lead sponsor.

NCT NCT02474017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02474017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Study to Assess the Robustness of the CRC749 Device by Pharmaceutical Performance Following Twice Daily Dosing of MGR001 Administered Via Oral Inhalation in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD)
Lead sponsor
Mylan Pharma UK Ltd.
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2015
Completion date
June 30, 2015
Enrollment
111 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, copd